One-year results from the FUTURE-II trial

Singapore Studio

Summary

This LBT session, which was originally presented during EuroPCR 2021, deals with the FUTURE-II study on the new generation of bioresorbable scaffolds, providing comparative safety and efficacy evidence of the thinner-strut PLLA-based BRS in the treatment of patients with noncomplex coronary lesions.